134 related articles for article (PubMed ID: 11289075)
21. Synthesis and chromatographic enantioresolution of anti-HIV quinolone derivatives.
Natalini B; Sardella R; Massari S; Ianni F; Tabarrini O; Cecchetti V
Talanta; 2011 Sep; 85(3):1392-7. PubMed ID: 21807200
[TBL] [Abstract][Full Text] [Related]
22. Antiviral properties of quinolone-based drugs.
Richter S; Parolin C; Palumbo M; Palù G
Curr Drug Targets Infect Disord; 2004 Jun; 4(2):111-6. PubMed ID: 15180459
[TBL] [Abstract][Full Text] [Related]
23. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
[TBL] [Abstract][Full Text] [Related]
24. Computer-aided design and discovery of protein-protein interaction inhibitors as agents for anti-HIV therapy.
Veselovsky AV; Zharkova MS; Poroikov VV; Nicklaus MC
SAR QSAR Environ Res; 2014; 25(6):457-71. PubMed ID: 24716798
[TBL] [Abstract][Full Text] [Related]
25. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
Wiles JA; Bradbury BJ; Pucci MJ
Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
[TBL] [Abstract][Full Text] [Related]
26. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
[TBL] [Abstract][Full Text] [Related]
27. Four-dimensional structure-activity relationship model to predict HIV-1 integrase strand transfer inhibition using LQTA-QSAR methodology.
de Melo EB; Ferreira MM
J Chem Inf Model; 2012 Jul; 52(7):1722-32. PubMed ID: 22657398
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.
Wang Z; Vince R
Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894
[TBL] [Abstract][Full Text] [Related]
29. 3D-QSAR and docking studies on the HEPT derivatives of HIV-1 reverse transcriptase.
Latha RS; Vijayaraj R; Singam ER; Chitra K; Subramanian V
Chem Biol Drug Des; 2011 Sep; 78(3):418-26. PubMed ID: 21689378
[TBL] [Abstract][Full Text] [Related]
30. Chemometric studies on the bactericidal activity of quinolones via an extended VolSurf approach.
Cianchetta G; Mannhold R; Cruciani G; Baroni M; Cecchetti V
J Med Chem; 2004 Jun; 47(12):3193-201. PubMed ID: 15163198
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives.
Santos Fda C; Abreu P; Castro HC; Paixão IC; Cirne-Santos CC; Giongo V; Barbosa JE; Simonetti BR; Garrido V; Bou-Habib DC; Silva Dde O; Batalha PN; Temerozo JR; Souza TM; Nogueira CM; Cunha AC; Rodrigues CR; Ferreira VF; de Souza MC
Bioorg Med Chem; 2009 Aug; 17(15):5476-81. PubMed ID: 19581097
[TBL] [Abstract][Full Text] [Related]
32. Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor.
Zhang C; Zhang H; Huang LS; Zhu S; Xu Y; Zhang XQ; Schooley RT; Yang X; Huang Z; An J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463393
[TBL] [Abstract][Full Text] [Related]
33. Molecular modeling, design, synthesis, and biological evaluation of novel 3',4'-dicamphanoyl-(+)-cis-khellactone (DCK) analogs as potent anti-HIV agents.
Xie L; Zhao CH; Zhou T; Chen HF; Fan BT; Chen XH; Ma JZ; Li JY; Bao ZY; Lo Z; Yu D; Lee KH
Bioorg Med Chem; 2005 Dec; 13(23):6435-49. PubMed ID: 16061386
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and binary QSAR study of antitubercular quinolylhydrazides.
Manvar A; Khedkar V; Patel J; Vora V; Dodia N; Patel G; Coutinho E; Shah A
Bioorg Med Chem Lett; 2013 Sep; 23(17):4896-902. PubMed ID: 23876988
[TBL] [Abstract][Full Text] [Related]
35. Predicting anti-HIV activity of PETT derivatives: CoMFA approach.
Ravichandran V; Agrawal RK
Bioorg Med Chem Lett; 2007 Apr; 17(8):2197-202. PubMed ID: 17307357
[TBL] [Abstract][Full Text] [Related]
36. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach.
Ravichandran V; Prashantha Kumar BR; Sankar S; Agrawal RK
Eur J Med Chem; 2009 Mar; 44(3):1180-7. PubMed ID: 18687505
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors.
He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337
[TBL] [Abstract][Full Text] [Related]
38. Aug-MIA-QSAR based strategy in bioactivity prediction of a series of flavonoid derivatives as HIV-1 inhibitors.
Muthukumaran P; Rajiniraja M
J Theor Biol; 2019 May; 469():18-24. PubMed ID: 30826336
[TBL] [Abstract][Full Text] [Related]
39. Nonclassical biological activities of quinolone derivatives.
Ahmed A; Daneshtalab M
J Pharm Pharm Sci; 2012; 15(1):52-72. PubMed ID: 22365088
[TBL] [Abstract][Full Text] [Related]
40. On the physical interpretation of QSAR models.
Stanton DT
J Chem Inf Comput Sci; 2003; 43(5):1423-33. PubMed ID: 14502475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
